Ariel Sobarzo

499 total citations
21 papers, 357 citations indexed

About

Ariel Sobarzo is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Ariel Sobarzo has authored 21 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ariel Sobarzo's work include Viral Infections and Outbreaks Research (11 papers), Viral Infections and Vectors (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Ariel Sobarzo is often cited by papers focused on Viral Infections and Outbreaks Research (11 papers), Viral Infections and Vectors (7 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Ariel Sobarzo collaborates with scholars based in Israel, Uganda and United States. Ariel Sobarzo's co-authors include Leslie Lobel, Julius J. Lutwama, John M. Dye, Sigal Gelkop, Rachel A. McKendry, Molly M. Stevens, Benjamin S. Miller, Claudio Parolo, Philip D. Howes and Robert S. Marks and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Ariel Sobarzo

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariel Sobarzo Israel 8 218 144 142 56 33 21 357
Krishnamurthy Konduru United States 11 234 1.1× 66 0.5× 106 0.7× 86 1.5× 14 0.4× 20 427
Katherine Schultheis United States 13 152 0.7× 43 0.3× 112 0.8× 70 1.3× 11 0.3× 22 345
Supriya Ravichandran United States 12 340 1.6× 40 0.3× 88 0.6× 95 1.7× 6 0.2× 21 479
Nguyễn Lê Khánh Hằng Vietnam 10 151 0.7× 76 0.5× 87 0.6× 283 5.1× 3 0.1× 15 416
Allen D. G. Roberts United Kingdom 7 182 0.8× 61 0.4× 139 1.0× 120 2.1× 4 0.1× 12 353
Daria Danilenko Russia 9 144 0.7× 40 0.3× 42 0.3× 138 2.5× 4 0.1× 55 300
Ute Eberle Germany 9 280 1.3× 132 0.9× 122 0.9× 73 1.3× 3 0.1× 16 396
Mingbin Liu China 13 109 0.5× 74 0.5× 190 1.3× 124 2.2× 2 0.1× 29 417
Aurélia Kwasiborski France 8 307 1.4× 195 1.4× 182 1.3× 58 1.0× 1 0.0× 15 493
Trisha R. Barnard Canada 6 165 0.8× 18 0.1× 118 0.8× 58 1.0× 21 0.6× 7 302

Countries citing papers authored by Ariel Sobarzo

Since Specialization
Citations

This map shows the geographic impact of Ariel Sobarzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Sobarzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Sobarzo more than expected).

Fields of papers citing papers by Ariel Sobarzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Sobarzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Sobarzo. The network helps show where Ariel Sobarzo may publish in the future.

Co-authorship network of co-authors of Ariel Sobarzo

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Sobarzo. A scholar is included among the top collaborators of Ariel Sobarzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Sobarzo. Ariel Sobarzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sobarzo, Ariel, et al.. (2025). Decoding NAMPT and TIGAR: A molecular blueprint for reprogramming tumor metabolism and immunity.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
Sobarzo, Ariel, et al.. (2025). Phospholipid-Rich DC-Vesicles with Preserved Immune Fingerprints: A Stable and Scalable Platform for Precision Immunotherapy. Biomedicines. 13(6). 1299–1299. 1 indexed citations
3.
Sobarzo, Ariel, et al.. (2025). PlP-powered exosomal therapeutics: Redefining immune activation in therapy-resistant tumor microenvironment.. Journal of Clinical Oncology. 43(16_suppl).
4.
5.
Sobarzo, Ariel, et al.. (2025). PlP-driven exosomal breakthroughs: Advancing immune solutions for complex tumor microenvironments.. Journal of Clinical Oncology. 43(16_suppl).
6.
7.
Sobarzo, Ariel, Liat Linde, Yael Refaely, et al.. (2024). Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration. Clinical & Translational Oncology. 26(9). 2227–2239. 2 indexed citations
8.
Sobarzo, Ariel, Yves Moné, Steven Lang, et al.. (2023). Long-term Sudan Virus Ebola Survivors Maintain Multiple Antiviral Defense Mechanisms. The Journal of Infectious Diseases. 230(2). 426–437. 2 indexed citations
9.
Sobarzo, Ariel, et al.. (2020). A36 Patient-Specific Humanized PDX Model for Overcoming Tumor Resistance to Immune Checkpoint Inhibitors in NSCLC Patients. Journal of Thoracic Oncology. 15(2). S24–S24. 3 indexed citations
10.
Sobarzo, Ariel, Spencer W. Stonier, Sigal Gelkop, et al.. (2019). Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. EBioMedicine. 46. 215–226. 2 indexed citations
11.
Sobarzo, Ariel, Claudio Parolo, Benjamin S. Miller, et al.. (2018). A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors. ACS Nano. 12(1). 63–73. 165 indexed citations
12.
Gelkop, Sigal, Ariel Sobarzo, Cécile Vincke, et al.. (2018). The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle. Frontiers in Veterinary Science. 5. 250–250. 27 indexed citations
13.
Stonier, Spencer W., Andrew S. Herbert, Ana I. Kuehne, et al.. (2017). Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses. The Journal of Experimental Medicine. 214(9). 2563–2572. 19 indexed citations
14.
Edri, Avishay, Michael Brusilovsky, Ariel Sobarzo, et al.. (2017). Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI. Scientific Reports. 7(1). 6054–6054. 11 indexed citations
15.
Sobarzo, Ariel, Spencer W. Stonier, Andrew S. Herbert, et al.. (2016). Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors. Viruses. 8(5). 133–133. 7 indexed citations
16.
Sobarzo, Ariel, Andrew S. Herbert, Ana I. Kuehne, et al.. (2015). Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks. Viruses. 7(1). 37–51. 17 indexed citations
17.
Sobarzo, Ariel, Allison Groseth, Olga Dolnik, et al.. (2013). Profile and Persistence of the Virus-Specific Neutralizing Humoral Immune Response in Human Survivors of Sudan Ebolavirus (Gulu). The Journal of Infectious Diseases. 208(2). 299–309. 43 indexed citations
18.
Sobarzo, Ariel, Allison Groseth, Olga Dolnik, et al.. (2012). Profiling the Native Specific Human Humoral Immune Response to Sudan Ebola Virus Strain Gulu by Chemiluminescence Enzyme-Linked Immunosorbent Assay. Clinical and Vaccine Immunology. 19(11). 1844–1852. 26 indexed citations
19.
Sobarzo, Ariel, Allison Groseth, Olga Dolnik, et al.. (2010). Detection of Sudan ebolavirus (strain Gulu) epitopes that are targets of the humoral immune response in survivors. International Journal of Infectious Diseases. 14. e461–e462. 2 indexed citations
20.
Sobarzo, Ariel, et al.. (2007). Optical fiber immunosensor for the detection of IgG antibody to Rift Valley fever virus in humans. Journal of Virological Methods. 146(1-2). 327–334. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krishnamurthy Konduru Breakdown of academic impact, for papers by Katherine Schultheis Breakdown of academic impact, for papers by Supriya Ravichandran Breakdown of academic impact, for papers by Nguyễn Lê Khánh Hằng Breakdown of academic impact, for papers by Allen D. G. Roberts Breakdown of academic impact, for papers by Daria Danilenko Breakdown of academic impact, for papers by Ute Eberle Breakdown of academic impact, for papers by Mingbin Liu Breakdown of academic impact, for papers by Aurélia Kwasiborski Breakdown of academic impact, for papers by Trisha R. Barnard
Rankless by CCL
2026